insulin degludec/insulin aspart 45

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

DiabetesDiabetes Mellitus, Type 1Healthy

Phase 1

Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

CompletedNCT01868555

Novo Nordisk A/SDiabetes, Healthy

Start: 2007-12-31End: 2008-02-29Updated: 2015-10-22

Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes

CompletedNCT01868568

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2008-04-30End: 2008-08-31Updated: 2015-10-22